Еxtraintestinal manifestations of inflammatory bowel disease
Abstract
Inflammatory bowel diseases, that include Crohn's disease and ulcerative colitis, are considered systemic processes since their symptoms and manifestations are not limited to the gastrointestinal tract. Extraintestinal manifestations are characteristic of inflammatory bowel disease and can be observed in almost every system of the patient’s body. Extraintestinal symptoms are present in approximately 42 % of patients with inflammatory bowel disease during the manifestation of the pathological process. They can also precede the onset of gastrointestinal symptoms. Nowadays, the pathogenesis of extraintestinal manifestations of inflammatory bowel disease is not completely obvious. It is currently believed that the mucous membrane of the patient's gastrointestinal tract can provoke an immune response in the extraintestinal areas due to the presence of common epitopes in individuals with a genetic predisposition. Extraintestinal symptoms are most often observed in the joints (peripheral and axial arthropathy), skin (nodular erythema, gangrenous pyoderma, aphthous stomatitis), visual organ (episcleritis, uveitis) and hepatobiliary system (primary sclerosing cholangitis). Other organs and systems of the body, such as the lungs, kidneys, pancreas and venous system, are also affected; however, their damages are much less common. Some extraintestinal manifestations, for instance arthritis of several joints, erythema nodosum, episcleritis, and aphthous ulcers of the oral cavity, are associated with inflammatory activity in the intestine. Other extraintestinal symptoms, such as uveitis and ankylosing spondylitis, are not associated with inflammatory bowel disease activity. Manifestations like primary sclerosing cholangitis and gangrenous pyoderma may or may not be associated with inflammatory bowel activity. Extraintestinal manifestations of inflammatory bowel disease exacerbate the negative impact of the pathological process on the patient's quality of life, and some of them, such as venous thromboembolism, can be life-threatening.
Downloads
References
Nóbrega, V. G., Silva, I. N. D. N., Brito, B. S., Silva, J., Silva, M. C. M. D., Santana, G. O. (2018). The onset of clinical manifestations in inflammatory bowel disease patients. Arquivos de gastroenterologia, 55(3), 290-295.
Vavricka, S. R., Schoepfer, A., Scharl, M., Lakatos, P. L., Navarini, A., Rogler, G. (2015). Extraintestinal manifestations of inflammatory bowel disease. Inflammatory bowel diseases, 21 (8), 1982-1992.
Chavez-Álvarez, S., Gómez-Flores, M., Ocampo-Candiani, J. (2016). Cutaneous manifestations in inflammatory bowel disease Gac Med Mex, 152 (5), 622-630.
Annese, V. (2019). A review of extraintestinal manifestations and complications of inflammatory bowel disease. Saudi journal of medicine & medical sciences, 7 (2), 66-73.
Ott, C., Schölmerich, J. (2013). Extraintestinal manifestations and complications in IBD. Nature reviews Gastroenterology & hepatology, 10 (10), 585-595.
Roth, N., Biedermann, L., Fournier, N., Butter, M., Vavricka, S. R., Navarini, A. A., ... Swiss IBD Cohort Study Group. (2019). Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study. PloS one, 14 (1), 1-16.
Huang, B. L., Chandra, S., & Shih, D. Q. (2012). Skin manifestations of inflammatory bowel disease. Frontiers in physiology, 3, 13.
Chan, J., Sari, I., Salonen, D., Silverberg, M. S., Haroon, N., Inman, R. D. (2018). Prevalence of sacroiliitis in inflammatory bowel disease using a standardized computed tomography scoring system. Arthritis care & research, 70 (5), 807-810.
Harbord, M., Annese, V., Vavricka, S. R., Allez, M., Barreiro-de Acosta, M., Boberg, K. M., ... & Juillerat, P. (2016). The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. Journal of Crohn's and Colitis, 10 (3), 239-254.
Olpin, J. D., Sjoberg, B. P., Stilwill, S. E., Jensen, L. E., Rezvani, M., & Shaaban, A. M. (2017). Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease. Radiographics, 37 (4), 1135-1160.
Restellini, S., Chazouillères, O., & Frossard, J. L. (2017). Hepatic manifestations of inflammatory bowel diseases. Liver International, 37 (4), 475-489.
Navaneethan, U., & Shen, B. (2010). Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflammatory bowel diseases, 16 (9), 1598-1619.
Oikonomou, K. A., Kapsoritakis, A. N., Stefanidis, I., & Potamianos, S. P. (2011). Drug-induced nephrotoxicity in inflammatory bowel disease. Nephron Clinical Practice, 119 (2), 89-96.
Tonolini, M., Villa, C., Campari, A., Ravelli, A., Bianco, R., & Cornalba, G. (2013). Common and unusual urogenital Crohn’s disease complications: spectrum of cross-sectional imaging findings. Abdominal imaging, 38 (1), 32-41.
Chams, S., Badran, R., Sayegh, S. E., Chams, N., Shams, A., & Hajj Hussein, I. (2019). Inflammatory bowel disease: Looking beyond the tract. International journal of immunopathology and pharmacology, 33, 2058738419866567.
Basseri, B., Enayati, P., Marchevsky, A., & Papadakis, K. A. (2010). Pulmonary manifestations of inflammatory bowel disease: case presentations and review. Journal of Crohn's and Colitis, 4 (4), 390-397.
Vizzardi, E., Sciatti, E., Bonadei, I., Bordonali, T., Ricci, C., Lanzarotto, F., ... & Metra, M. (2016). and ulcerative colitis: an echocardiographic case-control study. Panminerva medica, 58 (2), 115-20.
Mitchell, N. E., Harrison, N., Junga, Z., & Singla, M. (2018). Heart under attack: cardiac manifestations of inflammatory bowel disease. Inflammatory bowel diseases, 24 (11), 2322-2326.
Park, E. H., Kim, B. J., Huh, J. K., Jeong, E. H., Lee, S. H., Bang, K. B., ... & Kang, J. H. (2012). Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis. Journal of cardiovascular ultrasound, 20 (3), 154-156.
Tan, V. P., Chung, A., Yan, B. P., & Gibson, P. R. (2013). Venous and arterial disease in inflammatory bowel disease. Journal of gastroenterology and hepatology, 28 (7), 1095-1113.
Zezos, P., Kouklakis, G., & Saibil, F. (2014). Inflammatory bowel disease and thromboembolism. World Journal of Gastroenterology: WJG, 20 (38), 13863.
Singh, S., Singh, H., Loftus Jr, E. V., & Pardi, D. S. (2014). Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 12 (3), 382-393.
Pattanshetty, D. J., Anna, K., Gajulapalli, R. D., & Sappati-Biyyani, R. R. (2015). Inflammatory bowel “cardiac” disease: point prevalence of atrial fibrillation in inflammatory bowel disease population. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association, 21 (5), 325.
Kristensen, S. L., Ahlehoff, O., Lindhardsen, J., Erichsen, R., Jensen, G. V., Torp-Pedersen, C., ... & Hansen, P. R. (2013). Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death–a Danish nationwide cohort study. PloS one, 8 (2), e56944.
Kristensen, S. L., Ahlehoff, O., Lindhardsen, J., Erichsen, R., Lamberts, M., Khalid, U., ... & Hansen, P. R. (2014). Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish Nationwide Cohort study. Circulation: Heart Failure, 7 (5), 717-722.
Dorn, S. D., & Sandler, R. S. (2007). Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. American Journal of Gastroenterology, 102 (3), 662-667.
Vavricka, S. R., Brun, L., Ballabeni, P., Pittet, V., Vavricka, B. M. P., Zeitz, J., ... & Swiss IBD Cohort Study Group. (2011). Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. American Journal of Gastroenterology, 106 (1), 110-119.
Greuter, T., Navarini, A., & Vavricka, S. R. (2017). Skin manifestations of inflammatory bowel disease. Clinical reviews in allergy & immunology, 53 (3), 413-427.
Ardizzone, S., Puttini, P. S., Cassinotti, A., & Porro, G. B. (2008). Extraintestinal manifestations of inflammatory bowel disease. Digestive and Liver Disease, 40, S253-S259.
Farhi, D., Cosnes, J., Zizi, N., Chosidow, O., Seksik, P., Beaugerie, L., ... & Khosrotehrani, K. (2008). Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine, 87 (5), 281-293.
Levine, J. S., & Burakoff, R. (2011). Extraintestinal manifestations of inflammatory bowel disease. Gastroenterology & hepatology, 7 (4), 235.
Timani, S., & Mutasim, D. F. (2008). Skin manifestations of inflammatory bowel disease. Clinics in dermatology, 26 (3), 265-273.
Greuter, T., Navarini, A., & Vavricka, S. R. (2017). Skin manifestations of inflammatory bowel disease. Clinical reviews in allergy & immunology, 53 (3), 413-427.
Lankarani, K. B., Sivandzadeh, G. R., & Hassanpour, S. (2013). Oral manifestation in inflammatory bowel disease: a review. World journal of gastroenterology: WJG, 19 (46), 8571.
Harty, S., Fleming, P., Rowland, M., Crushell, E., McDermott, M., Drumm, B., & Bourke, B. (2005). A prospective study of the oral manifestations of Crohn’s disease. Clinical gastroenterology and hepatology, 3 (9), 886-891.
Arvikar, S. L., & Fisher, M. C. (2011). Inflammatory bowel disease associated arthropathy. Current reviews in musculoskeletal medicine, 4 (3), 123-131.
Malaty, H. M., Lo, G. H. W., & Hou, J. K. (2017). Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease. Clinical and experimental gastroenterology, 10, 259.
Bourikas, L. A., & Papadakis, K. A. (2009). Musculoskeletal manifestations of inflammatory bowel disease. Inflammatory bowel diseases, 15 (12), 1915-1924.
Salvarani, C., Fornaciari, G., Beltrami, M., & Macchioni, P. L. (2000). Musculoskeletal manifestations in inflammatory bowel disease. European journal of internal medicine, 11 (4), 210–214.
Rodríguez-Reyna, T. S., Martínez-Reyes, C., & Yamamoto-Furusho, J. K. (2009). Rheumatic manifestations of inflammatory bowel disease. World journal of gastroenterology: WJG, 15 (44), 5517.
Taleban, S., Li, D., Targan, S. R., Ippoliti, A., Brant, S. R., Cho, J. H., ... & Rotter, J. I. (2016). Ocular manifestations in inflammatory bowel disease are associated with other extra-intestinal manifestations, gender, and genes implicated in other immune-related traits. Journal of Crohn's and Colitis, 10 (1), 43-49.
Mady, R., Grover, W., & Butrus, S. (2015). Ocular complications of inflammatory bowel disease. TheScientificWorldJournal, 438402.
Cantini, F., Nannini, C., Cassarà, E., Kaloudi, O., & Niccoli, L. (2015). Uveitis in spondyloarthritis: an overview. The Journal of Rheumatology Supplement, 93, 27- 29.
Trost, L. B., & McDonnell, J. K. (2005). Important cutaneous manifestations of inflammatory bowel disease. Postgraduate medical journal, 81 (959), 580-585.
Danese, S., Semeraro, S., Papa, A., Roberto, I., Scaldaferri, F., Fedeli, G., Gasbarrini, G., & Gasbarrini, A. (2005). Extraintestinal manifestations in inflammatory bowel disease. World journal of gastroenterology, 11 (46), 7227–7236.
Rojas-Feria, M., Castro, M., Suárez, E., Ampuero, J., & Romero-Gómez, M. (2013). Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. World journal of gastroenterology: WJG, 19 (42), 7327.
Yarur, A. J., Czul, F., & Levy, C. (2014). Hepatobiliary manifestations of inflammatory bowel disease. Inflammatory bowel diseases, 20 (9), 1655-1667.
European Association For The Study Of The Liver. (2009). EASL Clinical Practice Guidelines: management of cholestatic liver diseases. Journal of hepatology, 51 (2), 237-267.
Ruffolo, C., Angriman, I., Scarpa, M., Polese, L., Pagano, D., Barollo, M., ... & D'Amico, D. F. (2006). Urologic complications in Crohn's disease: suspicion criteria. Hepato-gastroenterology, 53 (69), 357-360.
Poulou, A. C., Goumas, K. E., Dandakis, D. C., Tyrmpas, I., Panagiotaki, M., Georgouli, A., ... & Archimandritis, A. (2006). Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World Journal of Gastroenterology: WJG, 12 (5), 739.
Zezos, P., Kouklakis, G., & Saibil, F. (2014). Inflammatory bowel disease and thromboembolism. World Journal of Gastroenterology: WJG, 20 (38), 13863.
Baños Madrid, R., Salama Benarroch, H., Martínez Crespo, J., Morán Sánchez, S., Vargas Acosta, A., & Mercader Martínez, J. (2003, February). Complicaciones vasculares asociadas a la enfermedad inflamatoria intestinal. In Anales de medicina interna (Vol. 20, No. 2, pp. 33-36). Arán Ediciones, SL.
Ashrafi, M. R., Hosseini, F., Alizadeh, H., & Sani, M. N. (2013). Pseudotumor cerebri in a case of ulcerative colitis with sagittal sinus thrombosis. Iranian journal of pediatrics, 23 (1), 109.
Papa, A., Gerardi, V., Marzo, M., Felice, C., Rapaccini, G. L., & Gasbarrini, A. (2014). Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. World Journal of Gastroenterology: WJG, 20 (12), 3173.
Benavente, L., & Moris, G. (2011). Neurologic disorders associated with inflammatory bowel disease. European journal of neurology, 18(1), 138-143.
Plata-Bello, J., & Acosta-López, S. (2018). Neurological Manifestations of Inflammatory Bowel. New Concepts in Inflammatory Bowel Disease, 33.
Morís, G. (2014). Inflammatory bowel disease: an increased risk factor for neurologic complications. World Journal of Gastroenterology: WJG, 20 (5), 1228.
Abautret-Daly, Á., Dempsey, E., Parra-Blanco, A., Medina, C., & Harkin, A. (2018). Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta neuropsychiatrica, 30 (5), 275-296.
Graff, L. A., Walker, J. R., & Bernstein, C. N. (2009). Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflammatory bowel diseases, 15 (7), 1105-1118.
Nowakowski, J., Chrobak, A. A., & Dudek, D. (2016). Psychiatric illnesses in inflammatory bowel diseases-psychiatric comorbidity and biological underpinnings. Psychiatr Pol, 50 (6), 1157-1166.
Bannaga, A. S., & Selinger, C. P. (2015). Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clinical and experimental gastroenterology, 8, 111.
Panara, A. J., Yarur, A. J., Rieders, B., Proksell, S., Deshpande, A. R., Abreu, M. T., & Sussman, D. A. (2014). The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Alimentary pharmacology & therapeutics, 39 (8), 802-81
